LENSHIL 10MG CAPSULES

Lenshil 10mg Capsules contain lenalidomide, a potent immunomodulatory anticancer medicine prescribed for the treatment of multiple myeloma and select hematological malignancies. Lenalidomide works by inhibiting the growth of cancer cells, supporting immune system activity, and reducing the blood supply to tumors, helping to control disease progression.

This oral anticancer capsule is strictly used under the supervision of an oncologist due to its powerful effects and specific safety requirements.  Lenshil 10 mg Capsule is commonly included in combination therapy protocols for multiple myeloma, helping ensure effective management and improved patient outcomes.

Lenshil 10 mg Capsule meets international quality and safety requirements for prescription oncology medicines. It is suitable for hospital pharmacies, specialty oncology centers, and export supply.  Lenshil offers a reliable treatment option for advanced blood cancers when used as prescribed.

Product Features

• Immunomodulatory anticancer capsule
• Contains Lenalidomide 10 mg
• Used in multiple myeloma treatment
• Oral capsule dosage form
• Helps inhibit cancer cell growth
• Supports immune system modulation
• Manufactured under strict pharmaceutical quality standards
• Prescription-required medication

How It Helps

• Inhibits the growth of cancer cells in multiple myeloma and other blood cancers
• Supports and modulates the immune system to fight cancer more effectively
• Reduces blood supply to tumours, slowing disease progression
• Oral capsule form allows convenient administration under an oncologist’s supervision